| $350M | ||
| $172M | ||
| $127M | ||
| $109M | ||
| $107M | ||
| $100M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
IGC Pharma, Inc. operates as a pharmaceutical firm, currently in the clinical development phase, dedicated to pioneering novel treatments for Alzheimer's, a debilitating condition. The company's pipeline includes two experimental drug candidates aimed at this disease: IGC-AD1, which is presently undergoing a Phase 2 clinical study for addressing agitation associated with Alzheimer's-related dementia, and TGR-63, which is still in its preclinical stage. Beyond its therapeutic development efforts, IGC Pharma also explores the application of artificial intelligence (AI) to advance Alzheimer's research. Established on April 29, 2005, by Ram Mukunda, the company maintains its principal office in Potomac, Maryland.
Over the last 12 months, insiders at IGC Pharma, Inc. have bought $0 and sold $0 worth of IGC Pharma, Inc. stock.
On average, over the past 5 years, insiders at IGC Pharma, Inc. have bought $200,000 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 588,235 shares for transaction amount of $200,000 was made by Moran James P (director) on 2024‑09‑25.
| 2024-09-25 | Moran James P | director | 588,235 0.7705% | $0.34 | $200,000 | -0.41% | ||
| 2021-03-09 | Sale | PRINS RICHARD K | director | 50,000 0.1232% | $1.75 | $87,500 | -14.53% | |
| 2021-03-03 | Sale | PRINS RICHARD K | director | 50,000 0.1217% | $1.80 | $90,005 | -17.88% | |
| 2021-03-02 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 50,000 0.1328% | $2.14 | $107,000 | -24.10% | |
| 2020-12-01 | Sale | PRINS RICHARD K | director | 50,000 0.1364% | $2.04 | $102,000 | -12.71% | |
| 2020-11-30 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 80,000 0.1977% | $2.34 | $187,024 | -31.00% | |
| 2018-08-30 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 50,000 0.1644% | $1.87 | $93,260 | -32.04% | |
| 2018-08-30 | Sale | GRIMALDI CLAUDIA | Vice President and PFO | 116,020 0.409% | $2.00 | $232,040 | -32.04% | |
| 2018-08-28 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 125,000 0.4012% | $1.33 | $166,000 | -6.06% | |
| 2018-08-27 | Sale | GRIMALDI CLAUDIA | Vice President and PFO | 50,000 0.1154% | $1.10 | $55,000 | -17.76% | |
| 2018-08-27 | Sale | PRINS RICHARD K | director | 50,000 0.1133% | $1.08 | $54,000 | -17.76% | |
| 2018-08-24 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 25,000 0.0719% | $0.64 | $15,993 | +76.08% | |
| 2018-08-22 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 50,000 0.157% | $0.50 | $25,105 | +145.10% | |
| 2018-01-12 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 12,000 0.0418% | $1.05 | $12,600 | -42.60% | |
| 2018-01-11 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 12,000 0.044% | $1.12 | $13,400 | -43.13% | |
| 2018-01-10 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 12,000 0.0421% | $1.10 | $13,162 | -44.64% | |
| 2017-12-15 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 25,000 0.0911% | $0.76 | $19,000 | -9.46% | |
| 2017-12-14 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 25,000 0.088% | $0.75 | $18,750 | -11.38% | |
| 2017-12-08 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 54,950 0.2153% | $0.87 | $47,609 | -13.38% | |
| 2017-12-07 | Sale | MUKUNDA RAM | Exec. Chairman & CEO | 100,000 0.3833% | $0.85 | $85,300 | -13.92% |
| MUKUNDA RAM | Exec. Chairman & CEO | 2774760 2.7722% | $826,878.48 | 1 | 13 | |
| KRISHNA RANGA c | director | 1068461 1.0675% | $318,401.38 | 14 | 0 | +36.33% |
| Moran James P | director | 942402 0.9415% | $280,835.80 | 1 | 0 | <0.0001% |
| Oliveira Steven Michael | 10 percent owner | 772196 0.7715% | $230,114.41 | 1 | 5 | |
| PRINS RICHARD K | director | 620000 0.6194% | $184,760.00 | 1 | 5 | |
| GRIMALDI CLAUDIA | Vice President and PFO | 552987 0.5525% | $164,790.13 | 0 | 2 | |
| SHENOY SUDHAKAR V | director | 105000 0.1049% | $31,290.00 | 1 | 0 | |
| NGAI SHU KWONG | Interim CFO | 43100 0.0431% | $12,843.80 | 1 | 0 | |
| UBS AG | 10 percent owner | 31626 0.0316% | $9,424.55 | 65 | 65 | <0.0001% |
| D.B. ZWIRN & CO., L.P. | 0 0% | $0 | 0 | 1 |
| Increased Positions | 11 | +25.58% | 324,736 | +5.99% |
| Decreased Positions | 14 | -32.56% | 895,860 | -16.52% |
| New Positions | 6 | New | 113,691 | New |
| Sold Out Positions | 9 | Sold Out | 236,861 | Sold Out |
| Total Postitions | 40 | -6.98% | 5M | -10.53% |
| Renaissance Technologies Llc | $355.00 | 1.31% | 1.22M | +1M | +2,115.29% | 2025-09-30 |
| Vanguard Group Inc | $334.00 | 1.24% | 1.15M | +504,102 | +78.14% | 2025-09-30 |
| Geode Capital Management, Llc | $248.00 | 0.92% | 852,444 | +149,141 | +21.21% | 2025-09-30 |
| Blackrock, Inc. | $205.00 | 0.76% | 703,798 | 0 | 0% | 2025-09-30 |
| Citadel Advisors Llc | $183.00 | 0.68% | 627,840 | +356,874 | +131.7% | 2025-09-30 |
| State Street Corp | $47.00 | 0.17% | 160,207 | 0 | 0% | 2025-09-30 |
| Northern Trust Corp | $33.00 | 0.12% | 113,407 | 0 | 0% | 2025-09-30 |
| Virtu Financial Llc | $26.00 | 0.1% | 89,546 | +42,654 | +90.96% | 2025-09-30 |
| Dearborn Partners Llc | $25.00 | 0.09% | 84,401 | 0 | 0% | 2025-09-30 |
| Goldman Sachs Group Inc | $19.00 | 0.07% | 65,541 | 0 | 0% | 2025-09-30 |